Progression of late stent malapposition beyond 2 years after sirolimus-eluting stent implantation.
Ueno
Koji
K
Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Kawamura
Akio
A
Mintz
Gary S
GS
Weissman
Neil J
NJ
Jinzaki
Masahiro
M
Okabe
Teruo
T
Kobayakawa
Naoshi
N
Yamada
Minoru
M
Kuribayashi
Sachio
S
Ogawa
Satoshi
S
D054058:Acute Coronary Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects* / Q000295:instrumentation*; D002317:Cardiovascular Agents / Q000008:administration & dosage*; D017023:Coronary Angiography / Q000379:methods; D003324:Coronary Artery Disease / Q000628:therapy*; D054855:Drug-Eluting Stents; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D009102:Multiple Organ Failure / Q000209:etiology; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D020123:Sirolimus / Q000008:administration & dosage*; D013927:Thrombosis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D018084:Ultrasonography, Interventional
D002317:Cardiovascular Agents; D010975:Platelet Aggregation Inhibitors; D020123:Sirolimus